LSH Silicone Hydrogel Soft Hydrophilic Contact Lens for Daily Wear

November 25, 2012 updated by: Szabocsik and Associates, Inc.
This study is to evaluate the performance of the LSH (mangofilcon A) silicone hydrogel soft contact lenses when used as a daily wear contact lens for the correction of myopia.

Study Overview

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Huntington Beach, California, United States, 92647
        • Glenda Secor, OD
    • Hawaii
      • Honolulu, Hawaii, United States, 96814
        • Randall Sakamoto
    • Illinois
      • Oak Lawn, Illinois, United States, 60453
        • Robert Davis, OD
    • New Hampshire
      • Concord, New Hampshire, United States, 03301
        • Douglas P. Benoit, OD, FAAO
      • Londonderry, New Hampshire, United States, 03053
        • Stephen P. Byrnes, OD, FAAO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have been advised that the contact lenses they will be wearing for the next 3 months are being used for investigational purposes and that their informed consent will be needed and documented prior to the start of the study.
  • Visual acuity must be correctable to 20/30, with spherical lenses ranging in power from -1.00 to -5.00D, astigmatism≤1.50D.
  • Have been successfully wearing soft (hydrophilic) contact lenses for at least one month prior to entering the study. (Success means both subject and practitioner are satisfied with visual acuity, comfort, and ocular physiology).
  • Have non-diseased eyes which are normal or which have no preexisting ocular condition which would interfere with the patient's ability to adapt to the new pair of LSH Silicone Hydrogel Soft (hydrophilic) Contact Lenses. A normal eye is defined as one having all the following characteristics:

    1. No evidence of lid infection.
    2. No structural lid abnormality.
    3. No conjunctival abnormality or infection.
    4. A cornea which is clear with no edema, staining, vascularization or abnormal opacities, all as observed by slit lamp examination.
    5. No iritis.
    6. No other active ocular disease that would contraindicate use of the investigational lens.
    7. No GPC (giant papillary conjunctivitis, tarsal abnormality) Grade 2 or greater
  • Use no ocular medication.
  • Have no known sensitivity to solutions currently used for contact lens care.
  • Have binocular correction with contact lenses.

Exclusion Criteria

  • Astigmatism >1.50D
  • No monocular or monovision fits may be included.
  • Pregnant and lactating women are excluded from the study
  • Minors (under age 18) are excluded from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test Group myopia control
Subjects wearing contact lenses made of LSH (mangofilcon A) Soft (hydrophilic) Contact Lens for myopia control
Daily Wear
Active Comparator: Myopia Control
Subjects wearing Benz 3GX (hioxifilcon B) Soft (hydrophilic) Contact Lens for myopia control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity
Time Frame: 3 months
Snelling Scale
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Slit Lamp Findings
Time Frame: 3 months
Grading by the Slit Lamp Classification Scale
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: John M Szabocsik, PhD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

January 1, 2012

Study Registration Dates

First Submitted

June 11, 2012

First Submitted That Met QC Criteria

November 25, 2012

First Posted (Estimate)

November 28, 2012

Study Record Updates

Last Update Posted (Estimate)

November 28, 2012

Last Update Submitted That Met QC Criteria

November 25, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HF-2010-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Lagado LSH (mangofilcon A) Soft (hydrophilic) Contact Lens

3
Subscribe